CVS HEALTH CORPORATION (CVS) FY2024 YTD Q3 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

275,099,000,000 US dollars

Total operating costs

268,951,000,000 US dollars

Operating income

6,148,000,000 US dollars

Other income (expense), net (calculated)

negative 2,126,000,000 US dollars

Income before income tax provision

4,022,000,000 US dollars

Income tax provision

1,059,000,000 US dollars

Net income

2,963,000,000 US dollars

Products

169,610,000,000 US dollars

Services

12,108,000,000 US dollars

Premiums

91,983,000,000 US dollars

Net investment income

1,398,000,000 US dollars

Cost of products sold

151,019,000,000 US dollars

Health care costs

85,578,000,000 US dollars

Operating expenses

31,185,000,000 US dollars

Restructuring charges

1,169,000,000 US dollars

Loss on assets held for sale

0 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to CVS HEALTH CORPORATION: $2.97 B; to noncontrolling interests: −$7.00 M.